MoneyWorks4Me

Unjha Formulations - Quaterly Results

04 Aug 2026 Evaluate
The sales for the June 2026 quarter moved down to Rs. 33.07 millions as compared to Rs. 36.34 millions during the year-ago period.Net profit of the cmpany stood at Rs. 1.57 millions for the quarter ended June 2026 a decline of -59.64% from Rs. 3.89 millions  in the same quarter last year.Operating Profit reported a sharp decline to 1.95 millions from 4.20 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 33.07 36.34 -9.00 33.07 36.34 -9.00 157.49 139.77 12.68
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 1.95 4.20 -53.57 1.95 4.20 -53.57 11.04 6.30 75.24
Interest 0.01 0.02 -50.00 0.01 0.02 -50.00 0.08 0.08 0.00
PBDT 1.94 4.18 -53.59 1.94 4.18 -53.59 10.96 6.22 76.21
Depreciation 0.37 0.29 27.59 0.37 0.29 27.59 1.42 0.98 44.90
PBT 1.57 3.89 -59.64 1.57 3.89 -59.64 9.54 5.24 82.06
TAX 0.00 0.00 0.00 0.00 0.00 0.00 2.49 1.16 114.66
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.08 -0.01 700.00
PAT 1.57 3.89 -59.64 1.57 3.89 -59.64 7.05 4.08 72.79
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 5.90 11.56 -48.98 5.90 11.56 -48.98 7.01 4.51 55.52
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..